PRESS RELEASE published on 01/29/2025 at 15:42, 1 year 6 months ago Informations privilégiées / Autres communiqués Les ventes de UZEDY® par Teva Pharmaceuticals atteignent 117 M$ en 2024, dépassant les prévisions, Medincell perçoit des royalties. Préparation de lancement de l'Olanzapine LAI (TEV-749 / mdc-TJK) Royalties Medincell Teva Pharmaceuticals Olanzapine LAI UZEDY®
BRIEF published on 12/12/2024 at 21:35, 1 year 8 months ago Medincell Joins Euronext SBF 120 Index Market Capitalization Medincell CAC 40 Euronext SBF 120 Financial Visibility
BRIEF published on 12/12/2024 at 21:35, 1 year 8 months ago Medincell rejoint l'indice Euronext SBF 120 Capitalisation Boursière Visibilité Financière CAC 40 Euronext SBF 120 Médinecell
PRESS RELEASE published on 12/12/2024 at 21:30, 1 year 8 months ago Inside Information / Other news releases Medincell joins Euronext SBF 120 & CAC Mid 60 indices, enhancing visibility and investor appeal. Market capitalization-based indices by Euronext. Effective inclusion from Dec 20 Market Capitalization Medincell Index Inclusion Euronext SBF 120 CAC Mid 60
PRESS RELEASE published on 12/12/2024 at 21:30, 1 year 8 months ago Informations privilégiées / Autres communiqués Medincell intègre l'indice Euronext SBF 120 et CAC Mid 60, renforçant sa visibilité et attractivité pour les investisseurs. Découvrez les déclarations et impacts de cette intégration Euronext Intégration SBF 120 Medincell CAC Mid 60
PRESS RELEASE published on 12/10/2024 at 17:47, 1 year 8 months ago Medincell Rapport Financier semestriel 01-04-24 au 30-09-2024
BRIEF published on 11/28/2024 at 18:45, 1 year 8 months ago Medincell annonce une vidéoconférence pour ses résultats semestriels Résultats Semestriels Schizophrénie Medincell Videoconference Technologie BEPO
BRIEF published on 11/28/2024 at 18:45, 1 year 8 months ago Medincell Announces Video Conference for Half-Year Results Half-year Results Schizophrenia Medincell Videoconference BEPO Technology
PRESS RELEASE published on 11/28/2024 at 18:40, 1 year 8 months ago Informations privilégiées / Autres communiqués Medincell tiendra une vidéoconférence pour présenter ses résultats financiers semestriels le mardi 10 décembre 2024. La société développe des médicaments injectables à action prolongée dans divers domaines thérapeutiques Résultats Financiers Medincell Médicaments Injectables Videoconference Technologie BEPO
BRIEF published on 11/22/2024 at 18:05, 1 year 8 months ago MedinCell : Mise à jour du capital social et des droits de vote Droits De Vote Euronext Capital Social Actions Medincell
Published on 08/12/2026 at 23:30, 3 hours 16 minutes ago CCL Industries Announces Record Results for 2026 Second Quarter
Published on 08/12/2026 at 23:30, 3 hours 16 minutes ago Bolt Metals to Rebrand as 26 Metals Inc. and Adopt the Ticker "IRON," Highlighting Its Focus on Flagship Florália Iron Project in Brazil's Iron Quadrangle
Published on 08/12/2026 at 23:20, 3 hours 26 minutes ago RJK Explorations Ltd. Announces Upsize of Previously Announced Private Placement
Published on 08/12/2026 at 23:05, 3 hours 41 minutes ago Vox Royalty Reports Q2 2026 Results And Declares Quarterly Dividend
Published on 08/13/2026 at 02:00, 46 minutes ago A New Category Is Emerging in the Premium Residential Market — the 'Presidence'
Published on 08/13/2026 at 01:05, 1 hour 41 minutes ago Pepperstone Appoints New CTO to Drive AI-Native Proprietary Tech Push
Published on 08/12/2026 at 21:05, 5 hours 41 minutes ago Aurisco Pharmaceutical is the First Generic Oligonucleotide Manufacturer in the World successfully inspected by USFDA
Published on 08/12/2026 at 19:57, 6 hours 49 minutes ago EQS-Adhoc: Hypoport SE: Hypoport SE resolves share buyback programme with a volume of up to EUR 10 million
Published on 08/12/2026 at 19:37, 7 hours 9 minutes ago EQS-Adhoc: Brockhaus Technologies AG: Preliminary revenue for H1 2026 at €13.4 million and adjusted EBITDA at €-0.5 million; forecast for the continuing operations unchanged
Published on 08/11/2026 at 17:45, 1 day 9 hours ago DAMARTEX / Droits de vote bruts et réels au 31 juillet 2026
Published on 08/11/2026 at 17:40, 1 day 9 hours ago Infotel : Déclaration des transactions sur actions propres réalisées du 3 au 7 août 2026 dans le cadre du programme de rachat d’actions
Published on 08/10/2026 at 18:00, 2 days 8 hours ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026
Published on 08/10/2026 at 18:00, 2 days 8 hours ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/07/2026
